Literature DB >> 18818865

Novel HIV-1 long terminal repeat (LTR) sequences of subtype B and mosaic intersubtype B/C recombinants in North India.

Ujjwal Neogi1, Vikas Sood, Nidhi Goel, Ajay Wanchu, Akhil C Banerjea.   

Abstract

Although the HIV-1 epidemic in India is mainly due to subtype C, other subtypes have also been reported from different parts of India. HIV-1 LTR sequence analysis from six HIV-1 infected individuals from North India was carried out to determine the nature and extent of variations. Four out of six samples formed a unique phylogenetic cluster which was close to subtype B. The other two samples (A3 and S3) turned out to be novel mosaic recombinants showing resemblance to subtypes B, B/C-India and B/C-Myanmar gene segments. All four subtype B LTR samples and the two B/C recombinants showed conserved as well as unique polymorphisms in all of the putative transcription factor binding sites (TFBS). These changes may potentially alter basal as well as Tat-mediated HIV-1 LTR promoter activation. The two recombinants possessed three copies of the NF-kappaB TFBS as seen with the majority of subtype C and recombinant B/C isolates reported earlier, but the other four non-recombinant B-LTRs showed only two copies of the NF-kappaB site. This is the first study to show a dominance of unique subtype B-LTRs and strongly suggests that this region could also be a hot spot for the formation of highly complex inter subtype B/C recombinants.

Entities:  

Mesh:

Year:  2008        PMID: 18818865     DOI: 10.1007/s00705-008-0210-y

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

1.  Revisiting the recombinant history of HIV-1 group M with dynamic network community detection.

Authors:  Abayomi S Olabode; Garway T Ng; Kaitlyn E Wade; Mikhail Salnikov; Heather E Grant; David W Dick; Art F Y Poon
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-02       Impact factor: 12.779

2.  Genetic and functional analysis of HIV-1 Rev Responsive Element (RRE) sequences from North-India.

Authors:  Yogeshwar Sharma; Ujjwal Neogi; Vikas Sood; Snigdha Banerjee; Subodh Samrat; Ajay Wanchu; Surjit Singh; Akhil C Banerjea
Journal:  AIDS Res Ther       Date:  2010-08-03       Impact factor: 2.250

Review 3.  Genetic architecture of HIV-1 genes circulating in north India & their functional implications.

Authors:  Ujjwal Neogi; Vikas Sood; Larence Ronsard; Jyotsna Singh; Sneh Lata; V G Ramachandran; S Das; Ajay Wanchu; Akhil C Banerjea
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

4.  Molecular epidemiology of HIV-1 subtypes in India: origin and evolutionary history of the predominant subtype C.

Authors:  Ujjwal Neogi; Irene Bontell; Anita Shet; Ayesha De Costa; Soham Gupta; Vishal Diwan; Ranbir S Laishram; Ajay Wanchu; Udaykumar Ranga; Akhil C Banerjea; Anders Sönnerborg
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

5.  NF-κB Duplications in the Promoter-Variant HIV-1C LTR Impact Inflammation Without Altering Viral Replication in the Context of Simian Human Immunodeficiency Viruses and Opioid-Exposure.

Authors:  Rajnish S Dave; Haider Ali; Susmita Sil; Lindsey A Knight; Kabita Pandey; Lepakshe S V Madduri; Fang Qiu; Udaykumar Ranga; Shilpa Buch; Siddappa N Byrareddy
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

6.  Genetic analysis of HIV-1 Circulating Recombinant Form 02_AG, B and C subtype-specific envelope sequences from Northern India and their predicted co-receptor usage.

Authors:  Ujjwal Neogi; Vikas Sood; Arpita Chowdhury; Shukla Das; Vishnampettai G Ramachandran; Vijesh K Sreedhar; Ajay Wanchu; Nilanjana Ghosh; Akhil C Banerjea
Journal:  AIDS Res Ther       Date:  2009-12-03       Impact factor: 2.250

7.  Effect on HIV-1 gene expression, Tat-Vpr interaction and cell apoptosis by natural variants of HIV-1 Tat exon 1 and Vpr from Northern India.

Authors:  Sneh Lata; Larance Ronsard; Vikas Sood; Sajad A Dar; Vishnampettai G Ramachandran; Shukla Das; Akhil C Banerjea
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.